Concepedia

Author

Heleen Scheerens

Gilead Sciences (United States)

Also Known As

H Scheerens, H. Scheerens, HELEEN SCHEERENS, Heleen Scheerens, Scheerens, Heleen

58

Publications

6.5K

Citations

29

H-Index

62

Concepts

All Affiliations

Gilead Sciences (United States)Allergy Associates Research CenterUtrecht UniversityBaylor College of MedicineGenentech
HS

About

Heleen Scheerens is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

17

3.1K

2

Allergy

11

11

2.1K

3

Natural Sciences

2

2

105

4

Health Sciences

1

1

39

5

Social Sciences

1

1

49

Heleen Scheerens

×

32

Publications

6K

Citations

25

H-Index

YearCitations

IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6

David Yen, Jeanne Cheung, Heleen Scheerens,

Journal of Clinical Investigation

2006

1.5K

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania,

New England Journal of Medicine

2011

1.5K

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li,

ChemMedChem

2006

669

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren,

Thorax

2015

374

Membrane-Bound TNF Supports Secondary Lymphoid Organ Structure but Is Subservient to Secreted TNF in Driving Autoimmune Inflammation

Sigrid R. Ruuls, Robert M. Hoek, Vu N. Ngo,

Immunity

2001

248

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids

Michael Noonan, Phillip E. Korenblat, Sofia Mosesova,

Journal of Allergy and Clinical Immunology

2013

168

The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge

Heleen Scheerens, Joseph R. Arron, Yanan Zheng,

Clinical & Experimental Allergy

2013

125

Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production

Gail M. Gauvreau, Jeffrey M. Harris, Louis‐Philippe Boulet,

Science Translational Medicine

2014

121

Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch

Heleen Scheerens, A Malong, K Bassett,

Clinical and Translational Science

2017

117

Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10/ mice and Rag-2/ mice reconstituted with CD4+CD45RBhigh T cells

Heleen Scheerens, Edith M. Hessel, René de Waal Malefyt,

European Journal of Immunology

2001

106

Page 1